This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Delivered as Hybrid Event from 15-19 November 2021
Live In-Person Conference Delivered 15-17 NovemberSheraton Airport Brussels, Belgium
Menu
Book Now

Patrik Andersson, PhD
RNA Therapeutics Safety Lead at AstraZeneca

Agenda Sessions

  • RNA Therapeutics Safety

    On Demand
    View Session

  • Safety Issues Related to Chemically Modified Oligos and Conjugates

    16:30
    View Session

Speakers at this event

Prev
Next
Shalini Andersson, PhD
Chief Scientist New Therapeutic Modalities
AstraZeneca

See Patrik Speak

Register Now